Skip to main content

7 Result(s)

within G Schilling Remove this filter Hematology Remove this filter

and

  1. No Access

    Article

    Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT

    Although allogeneic hematopoietic stem cell transplantation (HSCT) features severe physical and psychological strain, no previous study has prospectively investigated fatigue beyond 3 years after transplantati...

    P Esser, K Kuba, A Mehnert, A Schwinn, L Schirmer… in Bone Marrow Transplantation (2017)

  2. No Access

    Article

    Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients

    Relapse after dose-reduced allograft in advanced myeloma patients remains high. To reduce the risk of relapse, we investigated a myeloablative toxicity-reduced allograft (aSCT) consisting of i.v. BU and CY fol...

    N Kröger, T Zabelina, E Klyuchnikov, M Kropff, K-H Pflüger… in Bone Marrow Transplantation (2013)

  3. No Access

    Article

    Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells

    We investigated efficacy and toxicity of lenalidomide in 24 heavily pretreated myeloma patients with a median age of 59 years (range: 37–70) and relapse after allo-SCT. Lenalidomide was given at a dose of 15 mg (

    M Lioznov, J El-Cheikh Jr, F Hoffmann, Y Hildebrandt, F Ayuk… in Bone Marrow Transplantation (2010)

  4. Article

    Erratum: Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma

    Correction to: Leukemia (2008) 22, 1250–1255; doi:10.1038/leu.2008.88 Since the publication of the above article, the authors have identified errors in the names of Dr J-A Pérez-Simón and Dr J San Miguel. The ...

    G Schilling, T Hansen, A Shimoni, T Zabelina, J-A Pérez-Simón, N C Gutierrez… in Leukemia (2008)

    Download PDF (50 KB) View Article

  5. No Access

    Article

    Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma

    We analyzed the prognostic impact of the most frequent genetic abnormalities detected by fluorescence in situ hybridization in 101 patients with multiple myeloma, who underwent allogeneic hematopoietic stem cell ...

    G Schilling, T Hansen, A Shimoni, T Zabelina, J-A Simon-Perez, N C Gutierrez… in Leukemia (2008)

  6. No Access

    Article

    High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis

    P Liebisch, C Wendl, A Wellmann, A Kröber, G Schilling, H Goldschmidt… in Leukemia (2003)

  7. No Access

    Article

    The novel t(11;12;18)(q21;q13;q21) represents a variant translocation of the t(11;18)(q21;q21) associated with MALT-type lymphoma

    J Dierlamm, EM Murga Penas, M Daibata, H Tagushi, K Hinz, M Baens, J Cools… in Leukemia (2002)